Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 25Neoplasm Metastasis 11Rectal Neoplasms 8Colorectal Cancer Metastatic 7Colonic Neoplasms 6Uterine Cervical Neoplasms 3Stomach Neoplasms 3Sarcoma 3Neoplasms 3Vulvar Neoplasms 2Vaginal Neoplasms 2Urinary Bladder Neoplasms 2Urethral Neoplasms 2Testicular Neoplasms 2Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Penile Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Melanoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Lymphocytic, Chronic, B-Cell 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2

Interventions

Sunitinib 5Specimen Handling 2Magnetic Resonance Spectroscopy 2Endoscopic Ultrasound-Guided Fine Needle Aspiration 2sapanisertib 1napabucasin 1lutetium Lu 177 dotatate 1lanreotide 1irinotecan sucrosofate 1cabozantinib 1aflibercept 1abemaciclib 1X-Rays 1Wound Healing 1Taxes 1Plastic Surgery Procedures 1Phantoms, Imaging 1Paclitaxel 1Oxaliplatin 1Octreotide 1Methods 1Melphalan 1Leucovorin 1Irinotecan 1Histocompatibility Testing 1Gemcitabine 1Fluorouracil 1Everolimus 1Cytoreduction Surgical Procedures 1Cryotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenoma, Islet Cell × aflibercept × Gastrointestinal × Clear all
NCT02159989 2025-10-20

Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 1 Completed
83 enrolled 21 charts
GastrointestinalGynecologic

Fibrolamellar hepatocellular carcinoma, Adenoma, Islet Cell, Neoplasm Metastasis, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡